Literature DB >> 1545828

Alteration of a cyclic AMP-dependent protein kinase phosphorylation site in the c-Fos protein augments its transforming potential.

I Tratner1, R Ofir, I M Verma.   

Abstract

We have studied the phosphorylation of the nuclear oncoprotein Fos by cyclic AMP-dependent protein kinase (PKA). We demonstrate that the human c-Fos protein, phosphorylated either in vitro with purified PKA or in vivo in JEG3 cells following treatment with forskolin, has similar phosphotryptic peptide maps. Serine 362, which constitutes part of a canonical PKA phosphorylation site (RKGSSS), is phosphorylated both in vivo and in vitro. A mutant of Fos protein in which serine residues 362 to 364 have been altered to alanine residues is not efficiently phosphorylated in vitro. Furthermore, Fos protein in which serines 362 to 364 have been altered to alanine shows increased transforming potential. We propose that phosphorylation of Fos by PKA is an important regulatory step in controlling its activity in normal cell growth and differentiation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1545828      PMCID: PMC369532          DOI: 10.1128/mcb.12.3.998-1006.1992

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  42 in total

1.  Isolation of human fos-related genes and their expression during monocyte-macrophage differentiation.

Authors:  M Matsui; M Tokuhara; Y Konuma; N Nomura; R Ishizaki
Journal:  Oncogene       Date:  1990-03       Impact factor: 9.867

Review 2.  Nuclear proto-oncogenes fos and jun.

Authors:  L J Ransone; I M Verma
Journal:  Annu Rev Cell Biol       Date:  1990

3.  Tissue-specific enhancer of the human glycoprotein hormone alpha-subunit gene: dependence on cyclic AMP-inducible elements.

Authors:  A M Delegeane; L H Ferland; P L Mellon
Journal:  Mol Cell Biol       Date:  1987-11       Impact factor: 4.272

4.  In vitro activation and nuclear translocation of NF-kappa B catalyzed by cyclic AMP-dependent protein kinase and protein kinase C.

Authors:  F Shirakawa; S B Mizel
Journal:  Mol Cell Biol       Date:  1989-06       Impact factor: 4.272

5.  Coupled and uncoupled induction of fos and jun transcription by different second messengers in cells of hematopoietic origin.

Authors:  J Auwerx; B Staels; P Sassone-Corsi
Journal:  Nucleic Acids Res       Date:  1990-01-25       Impact factor: 16.971

6.  Activation of the c-fos gene by UV and phorbol ester: different signal transduction pathways converge to the same enhancer element.

Authors:  M Büscher; H J Rahmsdorf; M Litfin; M Karin; P Herrlich
Journal:  Oncogene       Date:  1988-09       Impact factor: 9.867

7.  Multiple sequence elements of a single functional class are required for cyclic AMP responsiveness of the mouse c-fos promoter.

Authors:  L A Berkowitz; K T Riabowol; M Z Gilman
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 4.272

8.  Induction of the proto-oncogene fos by nerve growth factor.

Authors:  W Kruijer; D Schubert; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

9.  Phosphorylation of the v-erbA protein is required for its function as an oncogene.

Authors:  C Glineur; M Zenke; H Beug; J Ghysdael
Journal:  Genes Dev       Date:  1990-10       Impact factor: 11.361

10.  The product of a novel growth factor activated gene, fos B, interacts with JUN proteins enhancing their DNA binding activity.

Authors:  M Zerial; L Toschi; R P Ryseck; M Schuermann; R Müller; R Bravo
Journal:  EMBO J       Date:  1989-03       Impact factor: 11.598

View more
  15 in total

Review 1.  Nuclear protein phosphorylation and growth control.

Authors:  D W Meek; A J Street
Journal:  Biochem J       Date:  1992-10-01       Impact factor: 3.857

2.  Hypoxia-induced bFGF gene expression is mediated through the JNK signal transduction pathway.

Authors:  Y J Le; P M Corry
Journal:  Mol Cell Biochem       Date:  1999-12       Impact factor: 3.396

3.  Optimal transactivation by Epstein-Barr nuclear antigen 1 requires the UR1 and ATH1 domains.

Authors:  Gyanendra Singh; Siddhesh Aras; Arnold H Zea; Shahriar Koochekpour; Ashok Aiyar
Journal:  J Virol       Date:  2009-02-25       Impact factor: 5.103

4.  Involvement of protein kinase A in fibroblast growth factor-2-activated transcription.

Authors:  J P Pursiheimo; M Jalkanen; K Taskén; P Jaakkola
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

Review 5.  The regulation of protein transport to the nucleus by phosphorylation.

Authors:  D A Jans
Journal:  Biochem J       Date:  1995-11-01       Impact factor: 3.857

6.  Functions of Fos phosphorylation in bone homeostasis, cytokine response and tumourigenesis.

Authors:  L Bakiri; M O Reschke; H A Gefroh; M H Idarraga; K Polzer; R Zenz; G Schett; E F Wagner
Journal:  Oncogene       Date:  2010-11-29       Impact factor: 9.867

7.  The SV40 large T antigen and adenovirus E1a oncoproteins interact with distinct isoforms of the transcriptional co-activator, p300.

Authors:  M L Avantaggiati; M Carbone; A Graessmann; Y Nakatani; B Howard; A S Levine
Journal:  EMBO J       Date:  1996-05-01       Impact factor: 11.598

8.  The CREB, ATF-1, and ATF-2 transcription factors from bovine leukemia virus-infected B lymphocytes activate viral expression.

Authors:  E Adam; P Kerkhofs; M Mammerickx; A Burny; R Kettmann; L Willems
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

9.  Regulation of transforming growth factor-beta 1 expression by the hepatitis B virus (HBV) X transactivator. Role in HBV pathogenesis.

Authors:  Y D Yoo; H Ueda; K Park; K C Flanders; Y I Lee; G Jay; S J Kim
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

10.  Induction of the DNA-binding activity of c-jun/c-fos heterodimers by the hepatitis B virus transactivator pX.

Authors:  G Natoli; M L Avantaggiati; P Chirillo; A Costanzo; M Artini; C Balsano; M Levrero
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.